Facility Capital Planning Can Be Hard.
We Can Help.

Planning Your Facility is a High-Stakes Decision

Long-term Commitment

Planning facility space can be a long-term commitment spanning 5-10 years

High Impact

Wrong decisions impact cash flow, runway, and operational scalability

Unique Pressures

Early and mid-stage companies face unique pressures balancing growth with capital preservation

Expertise

Limited real estate expertise makes it difficult to know where to start

Eliminate the Guesswork in Your Life Science Real Estate Strategy.

Industry Expertise

The Facility Capital Planning Solution (FCPS)

is a proprietary planning platform developed by respected industry leaders Colliers, Gensler, DomeConstruction, and MGWest.

Bespoke Solution

Facility planning is not a one size fits all proposition.

Our custom tailored service starts with a simple questionnaire about your business, growth stage and roadmap, providing us the data to generate a bespoke solution that specifically fits your capital planning needs.

Market Alignment & Intelligence

Facility planning aligns the ever-changing market

landscape with your firm's current and future growth needs. Combining our real-time market data and industry expertise with the data-driven insights specific to your company lifecycle and growth stage, you can confidently plan your company's growth path forward.

Facility Capital Planning

Walking You Though Every Stage of Growth

Facility Planning Across Your Lifecycle

The Facility Capital Planning Tool determines optimal facility size based on your specific requirements through comprehensive life science construction metrics, facility lease costs across multiple locations, and capital demands for office and lab furniture β€” providing complete visibility into your real estate investment.

Stakeholder Benefits

For CEOs & Founders

Save time and focus on science. Get a clear roadmap aligned with your strategy and present confident plans to investors.

For CFOs & Finance

Precise capital budgets and cash flow visibility. Detail budgetary timing and protect your runway with phased deployment options.

For Boards & Investors

Confidence in management's planning. Data-backed facility strategy demonstrates thoughtful capital allocation.

Other Benefits

Funding

Protect runway with precise capital timing and spending forecasts. Compare market scenarios with real data to keep strategic options open as your company evolves and funding needs change.

Board Review

Present defensible facility plans with third-party validation and professional credibility. Demonstrate strategic alignment across hiring, funding, and development timelines for maximum impact.

Requirements & Decisions

Right-size your facility with data-driven insights that prevent costly mistakes. Save time with actionable planning tools instead of building models from scratch or chasing vendor quotes.

Three Simple Steps to Your Customized Capital Plan

STEP 1 Complete Survey
Step 1: Complete online survey (10-15 minutes) about your company, headcount, and markets
STEP 2 We Build Plan
Step 2: Our team builds your capital plan with real market data (3-5 business days)
STEP 3 Review Report
Step 3: Review comprehensive report and discuss next steps with our experts

What You'll Get

  • Facility Size Recommendations: Data-driven square footage based on headcount projections and lab/office mix
  • Capital Budget Breakdown: Detailed costs for tenant improvements, furniture, equipment, and soft costs with timing
  • Market Analysis: Compare multiple locations on cost, talent availability, and market conditions
  • Timeline & Phasing: Realistic project schedules from site selection to occupancy
  • Board-Ready Summary: Professional report for stakeholder presentations and decision-making
Start Your Assessment

Planning Partners

Gensler

Colliers

Colliers is a global leader in commercial real estate services, providing a wide range of services to clients including brokerage, investment management, property management, and consulting.

Gensler

Gensler

Gensler is a global architecture, design, and planning firm with 53 locations and more than 7,000 professionals networked across the Americas, Europe, Greater China, Asia Pacific, and the Middle East.

Dome Construction

Dome Construction

As the Bay Area's most trusted construction management services firm our reputation is built upon our extensive knowledge, unwavering professionalism, and exacting attention to detail since 1969.

MG West

MG West

Based in San Francisco, with offices in Silicon Valley and London, MG West manages interior projects ranging from 5k SF to over 500k SF annually with over one hundred years of service.

Developed By:

Occupier Services Bay Area Life Sciences Team

Our team of brokers, workplace strategists, project managers, strategic partners and dedicated support staff work together as a collaborative and accountable team to address your office and lab needs.

Global Experience

Extensive industry expertise with global industry knowledge and transaction execution.

More Than Brokers

Access our team of advisors and strategic partners with life science industry expertise.

Process Oriented

Refined processes that leverage technology to deliver seamless execution.

"Our mission is to develop and execute real estate strategy that is aligned with your business goals."

Years
0 β†’ 1
2 β†’ 3
4 β†’ 5
6 β†’ 7
8 β†’ 10+
Overall Business Stage
Seed
Concept validation Team formation IP development
Startup / Preclinical
Platform building IND-enabling studies Early partnerships
Clinical Stage
Phase 1-3 trials Regulatory milestones Clinical data generation
Pre-Commercial
BLA/NDA submission Manufacturing scale-up Commercial prep
Commercial / Growth
Product launch Market expansion Pipeline development
Funding Stage
Angel / Seed
$500K-$3M
Founders, angels Proof of concept
Series A
$5M-$20M
VCs enter IND enabling
Series B / C
$20M-$100M+
Clinical trials Multiple rounds
Crossover / IPO / FO
$100M-$500M+
Public markets Follow-on offerings
Non-dilutive / M&A
Grants, debt Partnerships Acquisition
Product / Clinical Stage
Discovery
Target ID Hit-to-lead Early screening
Preclinical (IND-enabling)
GLP tox studies CMC development IND filing
Phase 1 (Safety)
FIH studies 20-100 subjects Safety/PK/PD
Phase 2 (PoC)
100-300 patients Efficacy signals Dose finding
Phase 3 (Pivotal)
300-3000+ patients Confirmatory trials BLA/NDA submission
Facility Requirements
Incubator / Shared Lab
500-2K SF Benchtop space Shared equipment Flexible terms
Process Dev Labs + GLP
2K-10K SF Dedicated lab External GLP/CMO Basic office
GMP Clinical Supply
10K-30K SF GMP suites QC labs CMO partnerships
Tech Transfer & Launch
30K-75K SF Scale-up capacity QMS maturity Validation suites
Commercial Mfg
75K-250K+ SF Multi-product GMP Full QC/QA Distribution
People / Org Requirements
Founders + Core Science
2-10 people CSO, CEO Research scientists Advisors
Add CMC, Nonclinical, Finance
10-40 people CFO, COO CMC director Tox scientists
Clin Dev, Clin Ops, QA/RA, Med Affairs
40-120 people CMO, CCO Clinical team Regulatory affairs
Market Access, PV, Supply Chain
120-250 people Commercial team Manufacturing Supply chain
Sales, Marketing, Mfg, GxP Ops
250+ people Full commercial Sales force Operations